Pyrrolopyridazine MEK inhibitors-Reference-Cited by-同舟云学术

Pyrrolopyridazine MEK inhibitors

Published:2006-02 Issue:3 Volume:16 Page:628-632
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Chen Zhong,Kim Soong-Hoon,Barbosa Stephanie A.,Huynh Tram,Tortolani David R.,Leavitt Kenneth J.,Wei Donna D.,Manne Veeraswamy,Ricca Carolyn S.,Gullo-Brown Johnni,Poss Michael A.,Vaccaro Wayne,Salvati Mark E.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference24 articles.

1. The MAPK signaling cascade

2. Mitogen-activated protein kinase pathways

3. Hyperexpression of mitogen-activated protein kinase in human breast cancer.

4. A synthetic inhibitor of the mitogen-activated protein kinase cascade.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxidative cyclization of allyl compounds and isocyanide: A facile entry to polysubstituted 2-cyanopyrroles;Chinese Chemical Letters;2024-04

2. Studies of <i>N</i>-arylation of adamantane-containing amines using Chan-Lam reaction;Журнал органической химии;2023-12-15

3. Chan–Lam N-Arylation of Adamantane-Containing Amines;Russian Journal of Organic Chemistry;2023-12

4. Synthesis, Characterization and Cytotoxic Evaluation of New Pyrrolo[1,2-b]pyridazines Obtained via Mesoionic Oxazolo-Pyridazinones;International Journal of Molecular Sciences;2023-07-19

5. Discovery of MAP855, an Efficacious and Selective MEK1/2 Inhibitor with an ATP-Competitive Mode of Action;Journal of Medicinal Chemistry;2022-02-23